139 related articles for article (PubMed ID: 17886338)
1. Altered innate immunity in chronic hepatitis C infection: cause or effect?
Szabo G; Chang S; Dolganiuc A
Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
[No Abstract] [Full Text] [Related]
2. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
Hiroishi K; Ito T; Imawari M
J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
[TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatitis C: virologic and immunologic aspects].
Moriya K; Koike K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
[No Abstract] [Full Text] [Related]
6. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction.
Kanto T; Hayashi N
J Gastroenterol; 2004 Aug; 39(8):811-2. PubMed ID: 15338382
[No Abstract] [Full Text] [Related]
7. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
[TBL] [Abstract][Full Text] [Related]
8. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
9. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR
Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
[No Abstract] [Full Text] [Related]
10. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
Kanto T; Hayashi N
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
[No Abstract] [Full Text] [Related]
11. Immunology of hepatitis C virus infections.
Spaan M; Janssen HL; Boonstra A
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
Decalf J; Fernandes S; Longman R; Ahloulay M; Audat F; Lefrerre F; Rice CM; Pol S; Albert ML
J Exp Med; 2007 Oct; 204(10):2423-37. PubMed ID: 17893202
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of HCV persistence].
Hiroishi K; Ishii S; Imawari M
Nihon Rinsho; 2011 May; 69 Suppl 4():92-6. PubMed ID: 22096900
[No Abstract] [Full Text] [Related]
14. [Parameters of innate immunity in clinically manifested and subclinic forms of infections caused by hepatitis B and C viruses].
Gulieva AA; Mamedov MK; Dadasheva AE; Safarova SM
Georgian Med News; 2010 Nov; (188):29-33. PubMed ID: 21178200
[TBL] [Abstract][Full Text] [Related]
15. Immunology of hepatitis B and hepatitis C virus infections.
Boonstra A; Woltman AM; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells in innate immunity and cancer.
Becknell B; Caligiuri MA
J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751
[No Abstract] [Full Text] [Related]
17. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
18. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
20. [Activity of cytokines in chronic HCV-infected patients].
Lapiński TW; Dabrowska MM
Przegl Epidemiol; 2007; 61(4):747-54. PubMed ID: 18572507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
